Primary Record
Panobinostat
- In stock
- 695 g
- Purity
- 99.1 %
- CAS
- 404950-80-7
Compound Identifiers & Properties
- CAS
- 404950-80-7
- PubChem CID
- 6918837
- SMILES
- CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO
- Canonical SMILES
- Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1
Names & Synonyms
- Panobinostat
- 404950-80-7
- Faridak
- Farydak
- Panobinostat (LBH589)
- LBH589
- LBH-589
- Panobinostatum
- LBH 589
- Panobinostat [INN]
- panobinostat hydrate
- NVP-LBH589
- Panobinostat lactate
- Farydak (TN)
- Panobinostat(LBH589)
- Panobinostat [USAN:INN]
- RefChem:56999
- NVP-LBH-589
- Panobinostat & Mukungulu
- AC1OCFY8
- LBH-589B
- PANOBINOSTAT [MI]
- LBH589 - Panobinostat
- Panobinostat(LBH-589)
- Panobinostat (USAN/INN)
- D0E3SH
- PANOBINOSTAT [USAN]
- UNII-9647FM7Y3Z
- Panobinostat (LBH-589)
- 9647FM7Y3Z
- NVP LBH589
- MFCD09833242
- PANOBINOSTAT [MART.]
- panobinostat lactate anhydrous
- cc-487
- CHEBI:85990
- MLS006011216
- (E)-N-Hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylamide
- NVP-LBH 589
- PANOBINOSTAT [WHO-DD]
- SCHEMBL164801
- DTXSID40193506
- C21H23N3O2
- CHEMBL483254
- GTPL7489
- orb1305563
- SCHEMBL22773814
- BDBM29589
- CHEBI:93774
- 404950-80-7 (free base)
- DTXCID10115997
- EX-A169
- L01XX42
- FPOHNWQLNRZRFC-ZHACJKMWSA-N
- BCPP000187
- BDBM198124
- GLXC-90040
- HMS5079K05
- LBH-589/Panobinostat /LBH589
- AOB87727
- BCP01816
- LBH58,9NVP-LBH589,Panobinostat
- (LBH-589)
- ABP000143
- EBC-11340
- NSC761190
- s1030
- ZINC22010649
- AKOS005146046
- ACN-025765
- AN-1317
- BCP9000844
- CCG-208762
- CID6918837
- CS-0267
- DB06603
- EX-8456
- FH26749
- NSC-761190
- RL03555
- Panobinostat, NVP-LBH589, LBH589
- NCGC00263117-05
- NCGC00263117-07
- NCGC00263117-17
- 4CA-0964
- AC-28652
- AJ-80437
- AM808102
- AS-17046
- BC203264
- BR-77283
- HY-10224
- QC-10419
- SC-85907
- SMR004702978
- (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide
- AB0007883
- DB-025426
- RT-014934
- ST2402529
- A8178
- FT-0651457
- NS00071656
- SW219369-1
- W6096
- EC-000.2287
- J2.554.199E
- J3.451.397J
- (2E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide
- A10518
- A25218
- D10319
- W-5406
- EN300-7395075
- (E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE
- (E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide
- 139304-EP2270008A1
- 139304-EP2292617A1
- F091845
- Q7131441
- BRD-K02130563-001-07-2
- BRD-K02130563-001-11-4
- BRD-K02130563-001-12-2
- BRD-K02130563-001-14-8
- (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide
- (E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enehydroxamic acid
- 2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)-, (2E)-
- (E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl)acrylamide
- N-Hydroxy-3-[4-[2-(2-methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenamide
- 2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino) methyl)phenyl)-, (2E)-
- (E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl)prop-2-enamide
- (E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]acrylamide
- (E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]propeneamide
- N-hydroxy-3 -[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide
- N-Hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide
- N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide
- N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indole-3-yl)ethyl]amino]methyl]phenyl]acrylamide
- N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indole-3-yl)ethyl]amino]methyl]phenyl]propeneamide
- N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-2-propenamide
- (2E)-N-HYDROXY-3-(4-(((2-(2-METHYL-1H-INDOL-3-YL)ETHYL)AMINO)METHYL)PHENYL)PROP-2-ENAMIDE
- 2-Propenamide, N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
- 2-Propenamide, N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-; (2E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide; Farydak; LBH 589; Panobinostat
- 2-Propenamide,N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-,(2E)-
- N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide